Ertugliflozin in type 2 diabetes: a profile of its use Lesley J. Scott Adis Drug Q&A 03 July 2019 Pages: 351 - 362
Human α1-proteinase inhibitor (Respreeza®) in α1-antitrypsin deficiency emphysema: a profile of its use in the EU Hannah A. Blair Adis Drug Q&A 24 June 2019 Pages: 363 - 368
When managing ulcerative colitis in older patients, understanding their overall health profile is key Adis Medical Writers Disease Management 14 June 2019 Pages: 369 - 373
First reports of adverse drug reactions Drug Reactions and Interactions 04 July 2019 Pages: 374 - 375
Identify potentially inappropriate medications in older adults with chronic kidney disease and deprescribe when possible Adis Medical Writers Practical Issues and Updates 22 May 2019 Pages: 376 - 380
Intravenous medication errors in Selangor, Malaysia: prevalence, contributing factors and potential clinical outcomes Josephine Henry BasilJern Ni WongDevi Shantini Rata Mohan Original Research Article 15 May 2019 Pages: 381 - 390
The off-label use of medicines in pediatric outpatients in Bulgaria based on an analysis of their prescription data Maria DrenskaV. GrigorovaI. Getov Original Research Article 22 May 2019 Pages: 391 - 395
Management and evaluation of treatment adherence and effectiveness in chronic venous disorders: results of the international study VEIN Act Program Vadim BogachevJosé Manuel Jiménez ArribasAndres Marin Original Research Article Open access 27 May 2019 Pages: 396 - 404